AGP Executive Report
Last update: 8 hours agoDigital Health: FDA guidance clarifies when drug-connected apps count as labeling, prompting sponsors to plan clinical testing and software updates earlier. COPD Care: A hospital program combining discharge checklists, inhaler education, follow-up support and rehab referrals cut 30-day readmissions from 27.9% to 18.2%. Clinical Trials: Optum and Syneos Health are teaming up on a data- and AI-supported model to improve trial planning, recruitment and operations. Prescribing Ethics: A review of 93 studies linked pharmaceutical gifts and payments with more inappropriate prescribing, renewing concerns about industry influence on treatment choices. Drug Safety: One in six children taking GLP-1 drugs developed a nutritional deficiency within a year, but only 5% received nutrition counseling in the first month. Industry Deals: Merck is buying Silence Therapeutics for $1.3 billion to expand its RNA drug pipeline, while Roche struck a $15 billion deal with Hansoh for antibody-drug candidates.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
![<![CDATA[Syneos Health, Optum Partner on Adaptive Clinical Development Model]]>](https://2c717466dc25cd7041c9-8eeda6a8ca964cf210ed223dbc947813.ssl.cf2.rackcdn.com/29595374-950997367-debf5f0705bb52447c727542cc11c121da536cb5-3888x2592-200x133.jpeg)
![<![CDATA[American Pharmacists Month: How Technology Breeds Sustainable Pharmacy Practice]]>](https://2c717466dc25cd7041c9-8eeda6a8ca964cf210ed223dbc947813.ssl.cf2.rackcdn.com/29601293-951033307-73df852ec4646b1d6802552941c777702772d991-1800x1200-200x133.jpeg)
![<![CDATA[Harms of Public Health Measures Overlooked in COVID-19 Policy Reviews]]>](https://2c717466dc25cd7041c9-8eeda6a8ca964cf210ed223dbc947813.ssl.cf2.rackcdn.com/29601298-951033143-7c84f525d165111a827a5b2abae3efd184205b29-1799x1200-200x133.jpeg)
